{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:00:38Z","timestamp":1792425638805,"version":"4.5.0"},"reference-count":180,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Donor-derived infections are defined as any infection present in the donor that is transmitted to 1 or more recipients. Donor-derived infections can be categorized into 2 groups: \u201cexpected\u201d and \u201cunexpected\u201d infections. Expected transmissions occur when the donor is known to have an infection, such as positive serology for cytomegalovirus, Epstein Barr virus, or hepatitis B core antibody, at the time of donation. Unexpected transmissions occur when a donor has no known infection before donation, but 1 or more transplant recipients develop an infection derived from the common donor. Unexpected infections are estimated to occur in far less than 1% of solid organ transplant recipients. We will review the epidemiology, risk factors, and approaches to prevention and management of donor-derived viral infectious disease transmission in liver transplantation.<\/jats:p>","DOI":"10.1097\/tp.0000000000002326","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T12:39:45Z","timestamp":1530707985000},"page":"1824-1836","source":"Crossref","is-referenced-by-count":25,"title":["Donor-derived Viral Infections in Liver Transplantation"],"prefix":"10.1097","volume":"102","author":[{"given":"Hannah","family":"Nam","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy M.","family":"Nilles","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Colorado School of Medicine, Aurora, CO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Levitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Ison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/TP.0b013e318236cd02","article-title":"Uniform definitions for donor-derived infectious disease transmissions in solid organ transplantation","volume":"92","year":"2011","journal-title":"Transplantation"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/lt.23640","article-title":"Update on donor-derived infections in liver transplantation","volume":"19","year":"2013","journal-title":"Liver Transpl"},{"key":"bib4-20231002","first-page":"1","article-title":"Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs","volume":"43","year":"1994","journal-title":"MMWR Recomm Rep"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/ajt.14208","article-title":"Infection in Organ Transplantation","volume":"17","year":"2017","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"bib6-20231002","first-page":"93","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988-1994","volume":"43","year":"2006","journal-title":"Clin Infect Dis"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004","volume":"50","year":"2010","journal-title":"Clin Infect Dis"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","year":"2010","journal-title":"Rev Med Virol"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"e107645","DOI":"10.1371\/journal.pone.0107645","article-title":"Cytomegalovirus seroprevalence in pregnant women and association with adverse pregnancy\/neonatal outcomes in Jiangsu Province, China","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4254\/wjh.v6.i6.370","article-title":"Management of cytomegalovirus infection and disease in liver transplant recipients","volume":"6","year":"2014","journal-title":"World J Hepatol"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","year":"2013","journal-title":"Transplantation"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study","volume":"56","year":"2013","journal-title":"Clin Infect Dis"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-6143.2009.02861.x","article-title":"Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"10658","DOI":"10.3748\/wjg.v20.i31.10658","article-title":"Cytomegalovirus infection in liver transplant recipients: updates on clinical management","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/tri.12225","article-title":"Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a phase 2a study","volume":"27","year":"2014","journal-title":"Transpl Int"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","article-title":"Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"bib19-20231002","first-page":"S78","article-title":"Cytomegalovirus in solid organ transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/0-387-25342-4_3","article-title":"The ABC of Epstein-Barr virus infections","volume":"568","year":"2005","journal-title":"Adv Exp Med Biol"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/424447","article-title":"New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients","volume":"39","year":"2004","journal-title":"Clin Infect Dis"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/lt.500040612","article-title":"Fulminant Epstein-Barr viral hepatitis: orthotopic liver transplantation and review of the literature","volume":"4","year":"1998","journal-title":"Liver Transpl Surg"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3109\/0284186X.2013.844853","article-title":"A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival","volume":"53","year":"2014","journal-title":"Acta Oncol"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2214\/ajr.167.5.8911173","article-title":"Tumorous intrahepatic lymphoproliferative disorder in transplanted livers","volume":"167","year":"1996","journal-title":"AJR Am J Roentgenol"},{"issue":"Suppl 4","key":"bib25-20231002","first-page":"107","article-title":"Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib26-20231002","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/MOT.0b013e3283465715","article-title":"Posttransplant lymphoproliferative disease following liver transplantation","volume":"16","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"key":"bib27-20231002","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","year":"2016","journal-title":"Blood"},{"key":"bib28-20231002","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"bib29-20231002","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","year":"2009","journal-title":"Lancet"},{"key":"bib30-20231002","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jhep.2009.11.009","article-title":"Liver grafts from anti-hepatitis B core positive donors: a systematic review","volume":"52","year":"2010","journal-title":"J Hepatol"},{"key":"bib31-20231002","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/ajt.13187","article-title":"Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management","volume":"15","year":"2015","journal-title":"Am J Transplant"},{"key":"bib32-20231002","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s12250-017-4009-4","article-title":"Recent advances in the study of hepatitis B virus covalently closed circular DNA","volume":"32","year":"2017","journal-title":"Virol Sin"},{"key":"bib34-20231002","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/lt.23566","article-title":"Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation","volume":"19","year":"2013","journal-title":"Liver Transpl"},{"key":"bib35-20231002","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(94)90934-2","article-title":"\u201cOccult\u201d hepatitis B virus as source of infection in liver transplant recipients","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"bib36-20231002","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1002\/lt.20858","article-title":"Clinical reactivation after liver transplantation with an unusual minor strain of hepatitis B virus in an occult carrier","volume":"12","year":"2006","journal-title":"Liver Transpl"},{"key":"bib37-20231002","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5009\/gnl.2011.5.3.363","article-title":"Adult living donor liver transplantation using hepatitis B core antibody-positive grafts in Korea, a Hepatitis B-endemic region","volume":"5","year":"2011","journal-title":"Gut Liver"},{"key":"bib38-20231002","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1399-0012.2010.01211.x","article-title":"Low prevalence of HBV DNA in the liver allograft from anti\u2013HBc-positive donors: a single-center experience","volume":"25","year":"2011","journal-title":"Clin Transplant"},{"key":"bib39-20231002","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/1096-9071(200012)62:4<471::AID-JMV12>3.0.CO;2-X","article-title":"De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: analysis by determining complete sequence of the genome","volume":"62","year":"2000","journal-title":"J Med Virol"},{"key":"bib40-20231002","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/lt.20093","article-title":"Occult hepatitis B virus infection in HBsAg negative patients undergoing liver transplantation: clinical significance","volume":"10","year":"2004","journal-title":"Liver Transpl"},{"key":"bib41-20231002","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1600-6143.2009.02992.x","article-title":"Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report","volume":"10","year":"2010","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"bib42-20231002","first-page":"147","article-title":"Viral hepatitis in solid organ transplantation","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib43-20231002","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.trre.2010.05.001","article-title":"Review of the use of hepatitis B core antibody-positive kidney donors","volume":"24","year":"2010","journal-title":"Transplant Rev"},{"key":"bib44-20231002","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1111\/j.1399-0012.2011.01409.x","article-title":"Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts\u2014a systematic analysis","volume":"25","year":"2011","journal-title":"Clin Transplant"},{"key":"bib45-20231002","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/TP.0b013e3182845f97","article-title":"Prevention of de novo hepatitis B in recipients of core antibody-positive livers with lamivudine and other nucleos(t)ides: a 12-year experience","volume":"95","year":"2013","journal-title":"Transplantation"},{"key":"bib46-20231002","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1477-2574.2011.00399.x","article-title":"Utilization of hepatitis B core antibody-positive donor liver grafts","volume":"14","year":"2012","journal-title":"HPB (Oxford)"},{"key":"bib47-20231002","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.21998","article-title":"Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review","volume":"16","year":"2010","journal-title":"Liver Transpl"},{"key":"bib48-20231002","doi-asserted-by":"crossref","first-page":"E77","DOI":"10.1111\/j.1399-0012.2010.01329.x","article-title":"Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts","volume":"25","year":"2011","journal-title":"Clin Transplant"},{"key":"bib49-20231002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/gut.50.1.95","article-title":"Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors","volume":"50","year":"2002","journal-title":"Gut"},{"key":"bib50-20231002","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1600-6143.2006.01313.x","article-title":"Case report of lamivudine-resistant hepatitis B virus infection post liver transplantation from a hepatitis B core antibody donor","volume":"6","year":"2006","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"bib51-20231002","first-page":"311","article-title":"Vaccination in solid organ transplantation","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib52-20231002","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0264-410X(93)90278-6","article-title":"Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients","volume":"11","year":"1993","journal-title":"Vaccine"},{"key":"bib53-20231002","first-page":"1590","article-title":"Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial","volume":"85","year":"1990","journal-title":"Am J Gastroenterol"},{"key":"bib54-20231002","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0264-410X(84)90039-2","article-title":"HBV-vaccination in recipients of kidney allografts","volume":"2","year":"1984","journal-title":"Vaccine"},{"key":"bib55-20231002","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM198408233110803","article-title":"Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy","volume":"311","year":"1984","journal-title":"N Engl J Med"},{"key":"bib57-20231002","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrgastro.2013.216","article-title":"Management of patients with hepatitis B who require immunosuppressive therapy","volume":"11","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"bib59-20231002","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.transproceed.2012.05.077","article-title":"Liver transplantation from hepatitis B surface antigen-positive donors","volume":"45","year":"2013","journal-title":"Transplant Proc"},{"key":"bib60-20231002","first-page":"172","article-title":"Potential transmission of viral hepatitis through use of stored blood vessels as conduits in organ transplantation\u2014Pennsylvania, 2009","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bib62-20231002","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1111\/ajt.14381","article-title":"The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation","volume":"17","year":"2017","journal-title":"Am J Transplant"},{"key":"bib63-20231002","article-title":"A model to estimate the probability of human immunodeficiency virus and hepatitis C infection despite negative nucleic acid testing among increased-risk organ donors","volume":"19","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"bib64-20231002","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1600-6143.2011.03460.x","article-title":"Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib66-20231002","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1600-6143.2011.03597.x","article-title":"Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib67-20231002","article-title":"Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens","volume":"19","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"bib68-20231002","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/ajt.13283","article-title":"Transmission of hepatitis C virus from organ donors despite nucleic acid test screening","volume":"15","year":"2015","journal-title":"Am J Transplant"},{"key":"bib69-20231002","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1053\/jlts.2003.50208","article-title":"Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation","volume":"9","year":"2003","journal-title":"Liver Transpl"},{"key":"bib70-20231002","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/s00268-011-1019-5","article-title":"Survival after liver transplantation using hepatitis C virus-positive donor allografts: case-controlled analysis of the UNOS database","volume":"35","year":"2011","journal-title":"World J Surg"},{"key":"bib71-20231002","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/j.1432-2277.2010.01092.x","article-title":"Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis","volume":"23","year":"2010","journal-title":"Transpl Int"},{"key":"bib72-20231002","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.transproceed.2012.05.012","article-title":"Liver transplantation from anti-hepatitis C virus-positive donors: our experience","volume":"44","year":"2012","journal-title":"Transplant Proc"},{"key":"bib73-20231002","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/TP.0b013e318219eb8f","article-title":"Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study","volume":"91","year":"2011","journal-title":"Transplantation"},{"key":"bib74-20231002","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1034\/j.1600-6143.2003.00189.x","article-title":"Hepatitis C positive grafts may be used in orthotopic liver transplantation: a matched analysis","volume":"3","year":"2003","journal-title":"Am J Transplant"},{"key":"bib75-20231002","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1053\/jlts.2001.27088","article-title":"Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers","volume":"7","year":"2001","journal-title":"Liver Transpl"},{"key":"bib76-20231002","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0016-5085(99)70561-5","article-title":"Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts","volume":"117","year":"1999","journal-title":"Gastroenterology"},{"key":"bib77-20231002","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/00007890-199804150-00011","article-title":"Long-term outcome of patients transplanted with livers from hepatitis C-positive donors","volume":"65","year":"1998","journal-title":"Transplantation"},{"key":"bib78-20231002","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/j.1432-2277.2012.01498.x","article-title":"Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined","volume":"25","year":"2012","journal-title":"Transpl Int"},{"key":"bib79-20231002","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M13-1133","article-title":"Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010","volume":"160","year":"2014","journal-title":"Ann Intern Med"},{"key":"bib80-20231002","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0041-1345(00)01572-4","article-title":"Kidney transplantation from a donor who is HCV antibody positive and HCV-RNA negative","volume":"32","year":"2000","journal-title":"Transplant Proc"},{"key":"bib81-20231002","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1111\/ajt.12400","article-title":"Successful treatment of chronic HCV infection should not preclude kidney donation to an HCV negative recipient","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib82-20231002","doi-asserted-by":"crossref","first-page":"182","DOI":"10.6002\/ect.2012.0158","article-title":"Liver transplant from an ABO-incompatible and hepatitis C antibody-positive but an HCV-RNA negative living donor in a familial amyloid polyneuropathy patient","volume":"11","year":"2013","journal-title":"Exp Clin Transplant"},{"key":"bib83-20231002","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/j.gastro.2016.11.002","article-title":"Detection of occult hepatitis c virus infection in patients who achieved a sustained virologic response to direct-acting antiviral agents for recurrent infection after liver transplantation","volume":"152","year":"2017","journal-title":"Gastroenterology"},{"key":"bib84-20231002","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1053\/j.gastro.2016.12.015","article-title":"Occult hepatitis C virus infection: are we digging too deep?","volume":"152","year":"2017","journal-title":"Gastroenterology"},{"key":"bib85-20231002","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/hep.29704","article-title":"Hepatitis C transmission from seropositive, non-viremic donors to non-hepatitis C liver transplant recipients","volume":"67","year":"2018","journal-title":"Hepatology"},{"key":"bib86-20231002","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients","volume":"376","year":"2017","journal-title":"N Engl J Med"},{"key":"bib87-20231002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4254\/wjh.v4.i3.68","article-title":"Hepatitis A: Epidemiology and prevention in developing countries","volume":"4","year":"2012","journal-title":"World J Hepatol"},{"key":"bib88-20231002","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/jmv.20711","article-title":"High and persistent excretion of hepatitis A virus in immunocompetent patients","volume":"78","year":"2006","journal-title":"J Med Virol"},{"key":"bib89-20231002","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/trf.12648","article-title":"Case report of a transfusion-associated hepatitis A infection","volume":"54","year":"2014","journal-title":"Transfusion"},{"key":"bib90-20231002","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3201\/eid2304.161532","article-title":"Transmission of hepatitis A virus through combined liver-small intestine-pancreas transplantation","volume":"23","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"bib92-20231002","doi-asserted-by":"crossref","first-page":"9461","DOI":"10.3748\/wjg.v21.i32.9461","article-title":"Management of hepatitis delta: Need for novel therapeutic options","volume":"21","year":"2015","journal-title":"World J Gastroenterol"},{"key":"bib93-20231002","first-page":"243","article-title":"Delta hepatitis and infection in North America","volume":"382","year":"1993","journal-title":"Prog Clin Biol Res"},{"key":"bib94-20231002","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"bib95-20231002","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1111\/j.1600-6143.2012.04078.x","article-title":"Hepatitis E virus: what transplant physicians should know","volume":"12","year":"2012","journal-title":"Am J Transplant"},{"key":"bib96-20231002","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"bib97-20231002","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJMc0903778","article-title":"Persistent carriage of hepatitis E virus in patients with HIV infection","volume":"361","year":"2009","journal-title":"N Engl J Med"},{"key":"bib98-20231002","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/0003-4819-150-6-200903170-00026","article-title":"Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab","volume":"150","year":"2009","journal-title":"Ann Intern Med"},{"key":"bib99-20231002","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3201\/eid1701.100527","article-title":"Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France","volume":"17","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"bib100-20231002","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jhep.2011.06.021","article-title":"Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"bib101-20231002","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants","volume":"140","year":"2011","journal-title":"Gastroenterology"},{"key":"bib102-20231002","first-page":"19","article-title":"Evidence of hepatitis E virus transmission by renal graft","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"bib103-20231002","doi-asserted-by":"crossref","first-page":"ofx121","DOI":"10.1093\/ofid\/ofx121","article-title":"Hepatitis E virus-associated meningoencephalitis in a lung transplant recipient diagnosed by clinical metagenomic sequencing","volume":"4","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"bib104-20231002","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S1473-3099(08)70255-X","article-title":"Hepatitis E: an emerging infection in developed countries","volume":"8","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"bib105-20231002","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/j.transproceed.2010.05.034","article-title":"Unintended transplantation of three organs from an HIV-positive donor: report of the analysis of an adverse event in a regional health care service in Italy","volume":"42","year":"2010","journal-title":"Transplant Proc"},{"key":"bib106-20231002","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1111\/j.1600-6143.2012.04139.x","article-title":"Preventable errors in organ transplantation: an emerging patient safety issue?","volume":"12","year":"2012","journal-title":"Am J Transplant"},{"key":"bib107-20231002","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1600-6143.2010.03329.x","article-title":"Risk of window period HIV infection in high infectious risk donors: systematic review and meta-analysis","volume":"11","year":"2011","journal-title":"Am J Transplant"},{"key":"bib108-20231002","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrneph.2014.159","article-title":"Donor-derived infection\u2014the challenge for transplant safety","volume":"10","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"bib109-20231002","article-title":"Deceased organ donor screening for human immunodeficiency virus, hepatitis B, and hepatitis C viruses: discordant serology and nucleic acid testing results","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"bib110-20231002","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/ajt.13308","article-title":"An assessment of HIV-infected patients dying in care for deceased organ donation in a United States urban center","volume":"15","year":"2015","journal-title":"Am J Transplant"},{"key":"bib111-20231002","first-page":"26464","article-title":"Organ procurement and transplantation: implementation of the HIV Organ Policy Equity Act. Final rule","volume":"80","year":"2015","journal-title":"Fed Regist"},{"key":"bib112-20231002","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1111\/ajt.13824","article-title":"HIV-positive-to-HIV-positive liver transplantation","volume":"16","year":"2016","journal-title":"Am J Transplant"},{"key":"bib113-20231002","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/01.TP.0000058470.15921.CA","article-title":"Human T-cell leukemia virus type I infection in various recipients of transplants from the same donor","volume":"75","year":"2003","journal-title":"Transplantation"},{"issue":"Suppl 4","key":"bib114-20231002","first-page":"355","article-title":"Human T cell lymphotrophic virus 1\/2 in solid organ transplantation","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib115-20231002","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/TP.0b013e318263ad7a","article-title":"HTLV-1 in solid-organ transplantation: current challenges and future management strategies","volume":"94","year":"2012","journal-title":"Transplantation"},{"key":"bib116-20231002","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1600-6143.2012.04037.x","article-title":"Impact of human T cell leukemia virus type 1 in living donor liver transplantation","volume":"12","year":"2012","journal-title":"Am J Transplant"},{"key":"bib117-20231002","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/01.tp.0000235186.30113.c7","article-title":"Adult T-cell leukemia development from a human T-cell leukemia virus type I carrier after a living-donor liver transplantation","volume":"82","year":"2006","journal-title":"Transplantation"},{"key":"bib118-20231002","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/lt.21414","article-title":"Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"bib119-20231002","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00007890-200301150-00019","article-title":"Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor","volume":"75","year":"2003","journal-title":"Transplantation"},{"key":"bib120-20231002","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/jnnp.71.6.818","article-title":"Human T lymphotropic virus type I (HTLV-1) associated myelopathy acquired through a liver transplant","volume":"71","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"bib121-20231002","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1432-2277.2012.01434.x","article-title":"Human T-cell leukemia virus type 1 infection worsens prognosis of hepatitis C virus-related living donor liver transplantation","volume":"25","year":"2012","journal-title":"Transpl Int"},{"key":"bib122-20231002","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/TP.0b013e31819ebf76","article-title":"Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: is it safe?","volume":"87","year":"2009","journal-title":"Transplantation"},{"key":"bib123-20231002","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1182\/blood-2016-09-739433","article-title":"Screening transplant donors for HTLV-1 and -2","volume":"128","year":"2016","journal-title":"Blood"},{"issue":"Suppl 4","key":"bib124-20231002","first-page":"128","article-title":"Human herpesvirus 6, 7 and 8 in solid organ transplantation","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"bib125-20231002","first-page":"9","article-title":"Screening of donor and recipient in solid organ transplantation","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib126-20231002","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1086\/340237","article-title":"Reactivation of and primary infection with human herpesvirus 8 among solid-organ transplant recipients","volume":"185","year":"2002","journal-title":"J Infect Dis"},{"key":"bib127-20231002","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1097\/TP.0000000000001740","article-title":"Multicenter prospective study for laboratory diagnosis of HHV8 infection in solid organ donors and transplant recipients and evaluation of the clinical impact after transplantation","volume":"101","year":"2017","journal-title":"Transplantation"},{"key":"bib128-20231002","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM199811053391903","article-title":"Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"bib129-20231002","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/TP.0000000000000801","article-title":"Fatal outcome of multiple clinical presentations of human herpesvirus 8\u2013related disease after solid organ transplantation","volume":"100","year":"2016","journal-title":"Transplantation"},{"key":"bib130-20231002","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/TP.0b013e31823104ec","article-title":"Human herpes virus 8 in solid organ transplantation","volume":"92","year":"2011","journal-title":"Transplantation"},{"key":"bib131-20231002","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/lt.20058","article-title":"Fatal disseminated Kaposi's sarcoma following human herpesvirus 8 primary infections in liver-transplant recipients","volume":"10","year":"2004","journal-title":"Liver Transpl"},{"key":"bib132-20231002","first-page":"137291","article-title":"Visceral Kaposi's sarcoma related to human herpesvirus-8 in liver transplant recipient: case report and literature review","volume":"2012","year":"2012","journal-title":"Case Rep Oncol Med"},{"key":"bib133-20231002","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MOT.0b013e32814e6b67","article-title":"Transmission of viral disease to the recipient through the donor liver","volume":"12","year":"2007","journal-title":"Curr Opin Organ Transplant"},{"key":"bib134-20231002","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.medmal.2005.02.009","article-title":"Epidemiological aspects of human herpesvirus 8 infection and of Kaposi's sarcoma","volume":"35","year":"2005","journal-title":"Med Mal Infect"},{"key":"bib135-20231002","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00432-007-0329-3","article-title":"Kaposi's sarcoma after liver transplantation","volume":"134","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"bib136-20231002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.trim.2006.09.008","article-title":"Human herpesvirus-8 infection and Kaposi's sarcoma after liver and kidney transplantation in different geographical areas of Spain","volume":"17","year":"2006","journal-title":"Transpl Immunol"},{"key":"bib137-20231002","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.transproceed.2009.03.009","article-title":"Risk of Kaposi sarcoma after solid-organ transplantation: multicenter study in 4767 recipients in Italy, 1970\u20132006","volume":"41","year":"2009","journal-title":"Transplant Proc"},{"key":"bib138-20231002","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM200004063421407","article-title":"Kaposi's Sarcoma","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"bib139-20231002","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nm862","article-title":"Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors","volume":"9","year":"2003","journal-title":"Nat Med"},{"key":"bib140-20231002","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00007890-200007270-00030","article-title":"Persistent human herpesvirus 8 viremia before Kaposi's sarcoma development in a liver transplant recipient","volume":"70","year":"2000","journal-title":"Transplantation"},{"key":"bib141-20231002","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/00007890-199804270-00025","article-title":"Kaposi's sarcoma in liver transplant recipients on FK506","volume":"65","year":"1998","journal-title":"Transplantation"},{"key":"bib142-20231002","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/ajt.14516","article-title":"Donor-derived Kaposi's sarcoma in a liver-kidney transplant recipient","volume":"18","year":"2018","journal-title":"Am J Transplant"},{"key":"bib143-20231002","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2012-04-421412","article-title":"How I treat HHV8\/KSHV-related diseases in posttransplant patients","volume":"120","year":"2012","journal-title":"Blood"},{"key":"bib144-20231002","first-page":"845","article-title":"Outbreak of West Nile-like viral encephalitis\u2013New York, 1999","volume":"48","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bib145-20231002","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(01)05480-0","article-title":"Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey","volume":"358","year":"2001","journal-title":"Lancet"},{"key":"bib146-20231002","first-page":"1021","article-title":"West Nile virus infections in organ transplant recipients\u2014New York and Pennsylvania, August-September, 2005","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bib147-20231002","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/TP.0b013e31829b4142","article-title":"Fatal transplant-associated west nile virus encephalitis and public health investigation\u2014California, 2010","volume":"96","year":"2013","journal-title":"Transplantation"},{"key":"bib148-20231002","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1399-3062.2010.00595.x","article-title":"West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: case report and review of the literature","volume":"13","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"bib149-20231002","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1056\/NEJMoa022987","article-title":"Transmission of West Nile virus from an organ donor to four transplant recipients","volume":"348","year":"2003","journal-title":"N Engl J Med"},{"key":"bib150-20231002","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1086\/655146","article-title":"Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically","volume":"51","year":"2010","journal-title":"Clin Infect Dis"},{"key":"bib151-20231002","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/lt.20350","article-title":"Transmission of West Nile virus by organ transplantation","volume":"11","year":"2005","journal-title":"Liver Transpl"},{"key":"bib152-20231002","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/TP.0000000000000024","article-title":"Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features","volume":"97","year":"2014","journal-title":"Transplantation"},{"key":"bib153-20231002","first-page":"879","article-title":"Update: Investigations of West Nile virus infections in recipients of organ transplantation and blood transfusion\u2014Michigan, 2002","volume":"51","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bib154-20231002","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1001\/archneur.61.8.1210","article-title":"Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features","volume":"61","year":"2004","journal-title":"Arch Neurol"},{"key":"bib155-20231002","first-page":"10","article-title":"Serological diagnosis of West Nile virus","volume":"36","year":"2004","journal-title":"MLO Med Lab Obs"},{"key":"bib156-20231002","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2214\/ajr.184.3.01840957","article-title":"West Nile virus infection","volume":"184","year":"2005","journal-title":"AJR Am J Roentgenol"},{"issue":"Suppl 4","key":"bib157-20231002","first-page":"361","article-title":"Arenavirus and West Nile virus in solid organ transplantation","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"bib159-20231002","first-page":"22","article-title":"Donor-derived infections in solid organ transplantation","volume":"13","year":"2013","journal-title":"Am J Transplant"},{"key":"bib160-20231002","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1600-6143.2004.00519.x","article-title":"Screening for West Nile virus in organ transplantation: a medical decision analysis","volume":"4","year":"2004","journal-title":"Am J Transplant"},{"key":"bib161-20231002","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(04)15792-9","article-title":"Rabies and other lyssavirus diseases","volume":"363","year":"2004","journal-title":"The Lancet"},{"key":"bib162-20231002","article-title":"WHO Expert Consultation on Rabies","journal-title":"World Health Organ Tech Rep Ser"},{"key":"bib163-20231002","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1708-8305.2006.00095.x","article-title":"Organ transplantations and rabies transmission","volume":"14","year":"2007","journal-title":"J Travel Med"},{"key":"bib164-20231002","first-page":"586","article-title":"Investigation of rabies infections in organ donor and transplant recipients\u2013Alabama, Arkansas, Oklahoma, and Texas, 2004","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bib165-20231002","first-page":"615","article-title":"Update: Investigation of rabies infections in organ donor and transplant recipients\u2014Alabama, Arkansas, Oklahoma, and Texas, 2004","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bib166-20231002","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1001\/jama.2013.7986","article-title":"Raccoon rabies virus variant transmission through solid organ transplantation","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"bib167-20231002","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/vr.157.22.715","article-title":"Review of human rabies cases in the UK and in Germany","volume":"157","year":"2005","journal-title":"Vet Rec"},{"key":"bib168-20231002","first-page":"E050224.6","article-title":"Cases of rabies in Germany following organ transplantation","volume":"10","year":"2005","journal-title":"Euro Surveill"},{"key":"bib169-20231002","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3201\/eid2208.151993","article-title":"Probable rabies virus transmission through organ transplantation, China, 2015","volume":"22","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"bib170-20231002","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3201\/eid2309.161704","article-title":"Rabies virus transmission in solid organ transplantation, China, 2015\u20132016","volume":"23","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"bib171-20231002","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJM196604282741704","article-title":"Epidemic nonmeningitic lymphocytic-choriomeningitis-virus infection. an outbreak in a population of laboratory personnel","volume":"274","year":"1966","journal-title":"N Engl J Med"},{"key":"bib172-20231002","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/TP.0b013e31818b6548","article-title":"Emerging viruses in transplantation: there is more to infection after transplant than CMV and EBV","volume":"86","year":"2008","journal-title":"Transplantation"},{"key":"bib173-20231002","first-page":"799","article-title":"Brief report: Lymphocytic choriomeningitis virus transmitted through solid organ transplantation\u2014Massachusetts, 2008","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bib174-20231002","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1056\/NEJMp068021","article-title":"Lymphocytic choriomeningitis virus\u2013an old enemy up to new tricks","volume":"354","year":"2006","journal-title":"N Engl J Med"},{"key":"bib175-20231002","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa053240","article-title":"Transmission of lymphocytic choriomeningitis virus by organ transplantation","volume":"354","year":"2006","journal-title":"N Engl J Med"},{"key":"bib176-20231002","first-page":"537","article-title":"Lymphocytic choriomeningitis virus infection in organ transplant recipients\u2014Massachusetts, Rhode Island, 2005","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bib177-20231002","first-page":"249","article-title":"Notes from the field: a cluster of lymphocytic choriomeningitis virus infections transmitted through organ transplantation\u2014Iowa, 2013","volume":"63","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bib178-20231002","first-page":"19","article-title":"High clinical suspicion of donor-derived disease leads to timely recognition and early intervention to treat solid organ transplant-transmitted lymphocytic choriomeningitis virus","year":"2017","journal-title":"Transpl Infect Dis"},{"key":"bib179-20231002","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa073785","article-title":"A new arenavirus in a cluster of fatal transplant-associated diseases","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"bib180-20231002","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1016\/S1473-3099(16)30385-1","article-title":"Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen","volume":"17","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"bib181-20231002","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3201\/eid1606.091115","article-title":"Atypical chikungunya virus infections in immunocompromised patients","volume":"16","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"bib182-20231002","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/tid.12453","article-title":"Chikungunya infection in a human immunodeficiency virus-infected kidney transplant recipient returning to Italy from the Dominican Republic","volume":"17","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"bib183-20231002","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.ekir.2017.06.003","article-title":"Successful live kidney transplantation after chikungunya disease in the donor","volume":"2","year":"2017","journal-title":"Kidney Int Rep"},{"key":"bib184-20231002","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/bmj.324.7353.1563","article-title":"Dengue: an escalating problem","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"bib185-20231002","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jceh.2016.01.005","article-title":"Dengue virus transmission from living donor to recipient in liver transplantation: a case report","volume":"6","year":"2016","journal-title":"J Clin Exp Hepatol"},{"key":"bib186-20231002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40794-016-0032-y","article-title":"Update on non-vector transmission of dengue: relevant studies with Zika and other flaviviruses","volume":"2","year":"2016","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"bib187-20231002","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/1752-1947-8-378","article-title":"Dengue fever in a liver-transplanted patient: a case report","volume":"8","year":"2014","journal-title":"J Med Case Rep"},{"key":"bib188-20231002","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.mayocp.2016.12.019","article-title":"Zika virus meningoencephalitis in an immunocompromised patient","volume":"92","year":"2017","journal-title":"Mayo Clin Proc"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00007890-201811000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:47:38Z","timestamp":1786038458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007890-201811000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":180,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002326","relation":{},"ISSN":["1534-6080","0041-1337"],"issn-type":[{"value":"1534-6080","type":"electronic"},{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}